Abstract: Slide Presentations |


Nazima Nisar, PhD *; Randeep Guleria, MD; Arvind K. Singh, MD; Tirlok C. Chawla, PhD; Niranjan Nayak, MD; Nihar R. Biswas, MD
Author and Funding Information

Department of Ocular Pharmacology, Dr. R.P.Centre for Ophthalmic Sciences, All I, New Delhi, India


Chest. 2005;128(4_MeetingAbstracts):147S-c-148S. doi:10.1378/chest.128.4_MeetingAbstracts.147S-c
Text Size: A A A
Published online


PURPOSE:  Mycoplasma pneumoniae ( M . pneumoniae ), primarily recognized as a causative agent of community acquired pneumonia has recently been linked to asthma pathogenesis. The lack of awareness and appropriate diagnostic facilities handicap the current understanding of their true prevalence in asthma . Polymerase chain reaction (PCR) is emerging as one of the most accurate methods for the rapid identification of M. pneumoniae in asthmatics. The purpose of present study is to see the prevalence of M. pneumoniae in asthmatics using PCR, culture and serology.

METHODS:  Seventy nine adults (Aged 15-58 years) with stable asthma and 20 age matched healthy controls without any respiratory illness were evaluated for the presence of M. pneumoniae infection. Throat swabs collected from both the groups were subjected to culture as well as PCR for P1/P-30 gene. Serum samples were analyzed for IgM and IgG antibodies to M. pneumoniae using gelatin particle agglutination test and enzyme linked immunosorbent assay respectively.

RESULTS:  Seventeen ( 21.5%) asthmatics were found to be positive by PCR amplifying 153 bp and 825 bp fragments of P1 and P-30 genes respectively. Only 9 (11.4%) patients were positive for culture. High levels of IgG antibodies to M. pneumoniae were detected in the paired sera of 14 (17.7%)patients and 6 (7.6%) patients were positive for IgM antibodies. In normal controls, one sample was positive for only IgM antibodies at a titre of 1:80. This titre was taken as a cut off value while analyzing sera of patients with asthma.

CONCLUSION:  This is the first report from India showing the presence of M. pneumoniae in a significant group of asthmatics. Carefully controlled prospective studies are warranted to confirm this association in asthma using highly sensitive techniques.

CLINICAL IMPLICATIONS:  Given the possibility that M. pneumoniae is involved in the etiopathogenesis of asthma, treatment with antimicrobials active against M.pneumoniae in addition to standard therapy may help in better control of asthma.

DISCLOSURE:  Nazima Nisar, None.

Monday, October 31, 2005

2:30 PM - 4:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543